{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:51:07Z","timestamp":1792101067553,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcna.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:42:27Z","timestamp":1464223347000},"page":"719-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions"],"prefix":"10.1016","volume":"100","author":[{"given":"Alison M.","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.23929","article-title":"Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper","volume":"59","author":"American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mcna.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12916-015-0285-8","article-title":"Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis\u2013an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks","volume":"13","author":"Scarpignato","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.mcna.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat\u00a0Clin Pract Rheumatol"},{"key":"10.1016\/j.mcna.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.39333","article-title":"2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology Collaborative Initiative","volume":"67","author":"Dejaco","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.mcna.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.mcna.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","article-title":"Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis","volume":"4","author":"Narum","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.mcna.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine---update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.mcna.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.001_bib10","first-page":"1","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2015","journal-title":"Arthritis\u00a0Rheumatol"},{"key":"10.1016\/j.mcna.2016.03.001_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/nrrheum.2015.132","article-title":"Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk","author":"Stamp","year":"2015","journal-title":"Nat. Rev. Rheumatol. Online Publication"},{"issue":"11","key":"10.1016\/j.mcna.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.clinthera.2009.11.033","article-title":"Febuxostat: a selective xanthine-oxidase\/xanthine dehydrogenase inhibitor for the management of hyperuricemia in adults with gout","volume":"31","author":"Ernst","year":"2009","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.mcna.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/BOR.0000000000000035","article-title":"Uricosuric drugs: the once and future therapy for hyperuricemia?","volume":"26","author":"Bach","year":"2014","journal-title":"Curr. Opin. Rheumatol"},{"issue":"16","key":"10.1016\/j.mcna.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/11202830-000000000-00000","article-title":"Pegloticase in treatment-refractory chronic gout","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.mcna.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/acr.22294","article-title":"Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record","volume":"66","author":"Schmajuk","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.mcna.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.lpm.2014.03.007","article-title":"Hydroxychloroquine: a multifaceted treatment for lupus","volume":"43","author":"Costedoat-Chalumeau","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.mcna.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mcna.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematous","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.mcna.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/art.34498","article-title":"A\u00a0randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis","volume":"64","author":"Moreland","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mcna.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2165\/00003495-200565130-00008","article-title":"Sulfasalazine: a review of its use in the management of rheumatoid arthritis","volume":"66","author":"Plasker","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2006.12.011","article-title":"Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient","volume":"33","author":"Ranganath","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.mcna.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-015-0332-8","article-title":"Immunosuppressive drugs and fertility","volume":"10","author":"Leroy","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.mcna.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/rheumatology\/keg442","article-title":"Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine","volume":"43","author":"Clunie","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.mcna.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.10.003","article-title":"Treatment of rheumatoid arthritis: unraveling the conundrum","volume":"65","author":"Zampeli","year":"2015","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.mcna.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.mcna.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.mcna.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"37","key":"10.1016\/j.mcna.2016.03.001_bib30","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.mcna.2016.03.001_bib31","first-page":"91","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older\u2013United States, 2015","volume":"64","author":"Kim","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.mcna.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2016.03.001_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11926-014-0480-1","article-title":"Giant cell arteritis and polymyalgia rheumatica: an update","volume":"17","author":"Gonz\u00e1lez-Gay","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.mcna.2016.03.001_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712516000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T14:53:55Z","timestamp":1536677635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712516000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0025712516000316"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}